Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.8K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Seizures: Classification01:13

Seizures: Classification

2.5K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Seizures l: Introduction01:20

Seizures l: Introduction

43
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
43
Seizures ll: Types01:19

Seizures ll: Types

42
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biofluid-specific variations in circulating 5' transfer RNA fragments during ictal and interictal states in experimental temporal lobe epilepsy.

Epilepsia·2026
Same author

Integrating Microscopy Methods to Study Gene and Protein Expression alongside Metal Ion Distribution and Speciation: A Case Study of Iron within Pyramidal Neurons from Distinct Hippocampal CA1 Subregions.

Chemical & biomedical imaging·2026
Same author

SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response.

Epilepsia·2026
Same author

Imaging Scores in Subarachnoid Hemorrhage: Performance on Prediction of Functional Outcome, Mortality, and Complications.

Brain sciences·2026
Same author

Spectral profile of early ictal EEG patterns in status epilepticus predicts therapy response.

Epilepsy & behavior : E&B·2025
Same author

Blood-Brain Barrier Dysfunction, Edema Formation and Functional Recovery in Ischemic and Hemorrhagic Stroke: A Retrospective Study.

Neurology international·2025

Related Experiment Video

Updated: May 6, 2026

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.2K

If You Care About Autonomic Modulation-Do Not Let Seizure Seizure.

Matthias C Borutta1, Vayra Royle1, Christina Rothballer1

  • 1Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany.

Diagnostics (Basel, Switzerland)
|March 14, 2026
PubMed
Summary
This summary is machine-generated.

Temporal lobe epilepsy (TLE) patients show altered autonomic cardiovascular modulation, particularly reduced sympathetic activity in right TLE and parasympathetic activity with increased seizure frequency. These autonomic changes appear early in epilepsy, independent of disease duration or antiseizure medications.

Keywords:
autonomic dysregulationautonomic nervous systemdysautonomiaheart rate variabilitytemporal lobe epilepsy

More Related Videos

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

26.0K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.1K

Related Experiment Videos

Last Updated: May 6, 2026

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.2K
Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

26.0K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.1K

Area of Science:

  • Neurology
  • Cardiology
  • Autonomic Nervous System Research

Background:

  • Temporal lobe epilepsy (TLE) is associated with potential autonomic nervous system dysfunction.
  • Understanding autonomic cardiovascular modulation in TLE is crucial for patient management.
  • Hemispheric localization, seizure frequency, disease duration, and antiseizure medications (ASMs) may influence autonomic function in TLE.

Purpose of the Study:

  • To investigate associations between autonomic cardiovascular modulation and TLE characteristics.
  • To compare autonomic parameters in TLE patients with healthy controls.
  • To explore the influence of hemispheric localization, seizure frequency, disease duration, and ASMs on autonomic function in TLE.

Main Methods:

  • Prospective observational study involving 31 TLE patients (12 right TLE, 19 left TLE) and 30 healthy controls.
  • Cardiovascular autonomic modulation assessed using R-R intervals and blood pressure recordings.
  • Calculation of sympathetic, parasympathetic, and total autonomic modulation parameters; subgroup analyses performed.

Main Results:

  • No significant differences in overall bio-signals between right TLE, left TLE, and controls.
  • Slightly lower sympathetic and total autonomic modulation in right TLE patients compared to controls.
  • Reduced parasympathetic modulation observed in right TLE patients with polytherapy or no ASMs; decreased sympathetic modulation in TLE patients with <1 seizure/month, significant in left TLE.

Conclusions:

  • A trend towards lower sympathetic modulation in right TLE supports right hemispheric sympathetic regulation.
  • Decreased parasympathetic modulation with increased seizure frequency highlights the need for seizure control to prevent autonomic complications.
  • Autonomic alterations appear early in TLE, independent of disease duration; ASM side effects may not solely explain dysregulation.